Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Switzerland
/
Healthcare
Create a narrative
Sonova Holding Community
SWX:SOON Community
3
Narratives
written by author
0
Comments
on narratives written by author
39
Fair Values set
on narratives written by author
Create a narrative
Community Investing Ideas
Sonova Holding
Popular
Undervalued
Overvalued
Sonova Holding
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Low-Cost Rivals And Digital Shifts Will Erode Premium Pricing
Key Takeaways The rise of low-cost competitors, new technologies, and commoditization threatens Sonova's pricing power, market share, and overall growth prospects. Regulatory pressures, rising costs, and declining clinic profitability are undermining margins and limiting the company's ability to sustain earnings.
View narrative
CHF 189.00
FV
17.2% overvalued
intrinsic discount
4.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
15 days ago
author updated this narrative
Sonova Holding
AN
AnalystHighTarget
Consensus Narrative from 17 Analysts
Global Aging And AI Tech Will Shape Hearing Care
Key Takeaways Rapid adoption of innovative hearing aids and operational improvements are driving higher margins and earnings growth beyond historical trends. Strategic positioning in demographics, technology, and regulation ensures consistent market share gains and profitable, recurring revenue streams.
View narrative
CHF 333.46
FV
33.5% undervalued
intrinsic discount
7.27%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
15 days ago
author updated this narrative
Sonova Holding
AN
AnalystConsensusTarget
Consensus Narrative from 17 Analysts
Launch Of Infinio And Sphere Hearing Aids Will Drive Future Performance
Key Takeaways Successful product launches and innovative features in hearing aids and cochlear implants boost future sales potential and revenue growth. Strategic cost management and efficiency improvements are expected to enhance net margins and operational performance.
View narrative
CHF 260.47
FV
14.9% undervalued
intrinsic discount
5.34%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
23
users have followed this narrative
about 21 hours ago
author updated this narrative
Your Valuation for
SOON
SOON
Sonova Holding
Your Fair Value
CHF
Current Price
CHF 221.60
3.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
5b
2015
2018
2021
2024
2025
2027
2030
Revenue CHF 5.1b
Earnings CHF 707.3m
Advanced
Set Fair Value